175.00
-1.61
(-0.91%)
At close: January 10 at 4:00:00 PM EST
171.01
-3.99
(-2.28%)
After hours: January 10 at 5:47:57 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 9 | 11 | 12 |
| Avg. Estimate | -0.5 | -0.41 | -1.63 | -1.35 |
| Low Estimate | -0.67 | -0.56 | -1.8 | -1.97 |
| High Estimate | -0.31 | -0.25 | -1.42 | -0.61 |
| Year Ago EPS | -0.64 | -0.56 | -3.78 | -1.63 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 16 | 13 | 18 | 19 |
| Avg. Estimate | 409.91M | 426.01M | 1.63B | 1.79B |
| Low Estimate | 395.44M | 415.9M | 1.62B | 1.6B |
| High Estimate | 429.17M | 441.51M | 1.65B | 1.89B |
| Year Ago Sales | 311.11M | 367.74M | 1.08B | 1.63B |
| Sales Growth (year/est) | 31.76% | 15.85% | 50.67% | 9.98% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.71 | -0.75 | -0.68 | -0.59 |
| EPS Actual | -0.64 | -0.56 | -0.3 | -0.26 |
| Difference | 0.07 | 0.19 | 0.38 | 0.33 |
| Surprise % | 10.00% | 25.83% | 56.08% | 56.23% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.5 | -0.41 | -1.63 | -1.35 |
| 7 Days Ago | -0.49 | -0.42 | -1.61 | -1.37 |
| 30 Days Ago | -0.49 | -0.41 | -1.61 | -1.33 |
| 60 Days Ago | -0.55 | -0.44 | -2.07 | -1.28 |
| 90 Days Ago | -0.54 | -0.45 | -2.06 | -1.32 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | 8 | -- | 10 | 1 |
| Down Last 7 Days | -- | 1 | -- | 1 |
| Down Last 30 Days | 2 | 1 | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NTRA | 21.21% | 27.57% | 56.96% | 16.99% |
| S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Upgrades & Downgrades
| Maintains | Bernstein: Outperform to Outperform | 1/10/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 1/3/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 12/13/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 11/18/2024 |
| Maintains | Morgan Stanley: Overweight to Overweight | 11/14/2024 |
| Maintains | TD Cowen: Buy to Buy | 11/13/2024 |
Related Tickers
GH Guardant Health, Inc.
36.71
+0.31%
VCYT Veracyte, Inc.
41.54
-5.12%
ILMN Illumina, Inc.
136.69
-2.14%
TWST Twist Bioscience Corporation
43.60
-3.37%
EXAS Exact Sciences Corporation
56.50
-0.32%
GRAL GRAIL, Inc.
17.73
+0.40%
PSNL Personalis, Inc.
5.59
-0.18%
TMO Thermo Fisher Scientific Inc.
542.31
-0.48%
RDNT RadNet, Inc.
68.78
-4.80%
IDXX IDEXX Laboratories, Inc.
418.05
-3.31%